Chapter 1. Introduction


1.1. Report Description and Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology



Chapter 2. Executive Summary


2.1. Global Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)

2.2. Global Monoclonal Antibody Therapeutics Market: Snapshot



Chapter 3. Monoclonal Antibody Therapeutics Market- Market Dynamics


3.1. Introduction

3.2. Market Drivers


3.2.1. Global Monoclonal Antibody Therapeutics Market Drivers: Impact Analysis

3.2.2. Growing Monoclonal Antibody Therapeutics Consumption in Developing Countries

3.2.3. Changing Consumption Habits of Monoclonal Antibody Therapeutics

3.3. Market Restraints


3.3.1. Global Monoclonal Antibody Therapeutics Market Restraints: Impact Analysis

3.3.2. High Taxation in Monoclonal Antibody Therapeutics Business and Trade

3.4. Opportunities


3.4.1. Innovative Products with Flavored Monoclonal Antibody Therapeutics

3.5. Porters Five Forces Analysis


3.5.1. Bargaining Power of Suppliers

3.5.2. Bargaining Power of Buyers

3.5.3. Threat from New Entrants

3.5.4. Threat from New Substitutes

3.5.5. Degree of Competition

3.6. Market Attractiveness Analysis


3.6.1. Market Attractiveness Analysis, by Application Segment

3.6.2. Market Attractiveness Analysis, by Source Segment

3.6.3. Market Attractiveness Analysis, by End User Segment

3.6.4. Market Attractiveness Analysis, by Regional Segment



Chapter 4. Global Monoclonal Antibody Therapeutics Market- Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global Monoclonal Antibody Therapeutics Market: Company Market Share, 2017

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Product Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development and Regional Expansion

4.3. Price Trend Analysis



Chapter 5. Global Monoclonal Antibody Therapeutics Market- Application Segment Analysis


5.1. Global Monoclonal Antibody Therapeutics Market: Application Overview


5.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Application, 2017 and 2023

5.2. Cancer


5.2.1. Global Monoclonal Antibody Therapeutics Market for Cancer, 2015 - 2023 (USD Billion)

5.3. Autoimmune Diseases


5.3.1. Global Monoclonal Antibody Therapeutics Market for Autoimmune Diseases, 2015 - 2023 (USD Billion)

5.4. Infection


5.4.1. Global Monoclonal Antibody Therapeutics Market for Infection, 2015 - 2023 (USD Billion)

5.5. Hematological Diseases


5.5.1. Global Monoclonal Antibody Therapeutics Market for Hematological Diseases, 2015 - 2023 (USD Billion)

5.6. Others


5.6.1. Global Monoclonal Antibody Therapeutics Market for Others, 2015 - 2023 (USD Billion)



Chapter 6. Global Monoclonal Antibody Therapeutics Market- Source Segment Analysis


6.1. Global Monoclonal Antibody Therapeutics Market: Source Overview


6.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Source, 2017 and 2023

6.2. Human


6.2.1. Global Monoclonal Antibody Therapeutics Market for Human, 2015 - 2023 (USD Billion)

6.3. Humanized


6.3.1. Global Monoclonal Antibody Therapeutics Market for Humanized, 2015 - 2023 (USD Billion)

6.4. Chimeric


6.4.1. Global Monoclonal Antibody Therapeutics Market for Chimeric, 2015 - 2023 (USD Billion)

6.5. Others


6.5.1. Global Monoclonal Antibody Therapeutics Market for Others, 2015 - 2023 (USD Billion)



Chapter 7. Global Monoclonal Antibody Therapeutics Market- End User Segment Analysis


7.1. Global Monoclonal Antibody Therapeutics Market: End User Overview


7.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by End User, 2017 and 2023

7.2. Hospitals


7.2.1. Global Monoclonal Antibody Therapeutics Market for Hospitals, 2015 - 2023 (USD Billion)

7.3. Private Clinics


7.3.1. Global Monoclonal Antibody Therapeutics Market for Private Clinics, 2015 - 2023 (USD Billion)

7.4. Research Institutes


7.4.1. Global Monoclonal Antibody Therapeutics Market for Research Institutes, 2015 - 2023 (USD Billion)



Chapter 8. Global Monoclonal Antibody Therapeutics Market- Regional Segment Analysis


8.1. Global Monoclonal Antibody Therapeutics Market: Regional Overview


8.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Region, 2017 And 2023

8.2. North America


8.2.1. North America Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)

8.2.2. North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.2.3. North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.2.4. North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.2.5. U.S.


8.2.5.1. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.2.5.2. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.2.5.3. U.S. Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.2.6. Rest of North America


8.2.6.1. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.2.6.2. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.2.6.3. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.3. Europe


8.3.1. Europe Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)

8.3.2. Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.3.3. Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.3.4. Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.3.5. UK


8.3.5.1. UK Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.3.5.2. UK Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.3.5.3. UK Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.3.6. Germany


8.3.6.1. Germany Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.3.6.2. Germany Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.3.6.3. Germany Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.3.7. France


8.3.7.1. France Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.3.7.2. France Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.3.7.3. France Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.3.8. Rest of Europe


8.3.8.1. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.3.8.2. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.3.8.3. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.4. Asia Pacific


8.4.1. Asia Pacific Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)

8.4.2. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.4.3. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.4.4. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.4.5. China


8.4.5.1. China Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.4.5.2. China Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.4.5.3. China Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.4.6. Japan


8.4.6.1. Japan Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.4.6.2. Japan Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.4.6.3. Japan Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.4.7. India


8.4.7.1. India Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.4.7.2. India Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.4.7.3. India Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.4.8. Rest of Asia Pacific


8.4.8.1. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.4.8.2. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.4.8.3. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.5. Latin America


8.5.1. Latin America Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)

8.5.2. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.5.3. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.5.4. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.5.5. Brazil


8.5.5.1. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.5.5.2. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.5.5.3. Brazil Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.5.6. Rest of Latin America


8.5.6.1. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.5.6.2. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.5.6.3. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

8.6. Middle East and Africa


8.6.1. Middle East and Africa Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)

8.6.2. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)

8.6.3. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)

8.6.4. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)



Chapter 9. Company Profile


9.1. Pfizer Inc.


9.1.1. Overview

9.1.2. Financials

9.1.3. Product Portfolio

9.1.4. Business Strategy

9.1.5. Recent Developments

9.2. Bayer AG


9.2.1. Overview

9.2.2. Financials

9.2.3. Product Portfolio

9.2.4. Business Strategy

9.2.5. Recent Developments

9.3. Sanofi


9.3.1. Overview

9.3.2. Financials

9.3.3. Product Portfolio

9.3.4. Business Strategy

9.3.5. Recent Developments

9.4. Merck Co., Inc.


9.4.1. Overview

9.4.2. Financials

9.4.3. Product Portfolio

9.4.4. Business Strategy

9.4.5. Recent Developments

9.5. GlaxoSmithKline Plc.


9.5.1. Overview

9.5.2. Financials

9.5.3. Product Portfolio

9.5.4. Business Strategy

9.5.5. Recent Developments

9.6. F. Hoffmann-La Roche Ltd.


9.6.1. Overview

9.6.2. Financials

9.6.3. Product Portfolio

9.6.4. Business Strategy

9.6.5. Recent Developments

9.7. Novartis AG


9.7.1. Overview

9.7.2. Financials

9.7.3. Product Portfolio

9.7.4. Business Strategy

9.7.5. Recent Developments

9.8. Holdings AbbVie Inc.


9.8.1. Overview

9.8.2. Financials

9.8.3. Product Portfolio

9.8.4. Business Strategy

9.8.5. Recent Developments